Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term colon-cancer. Found 20 abstracts

Zijoo R, Olszanski AJ, Weinberg DS. Biomarkers and stage II colorectal cancer therapy. Translational Cancer Research. 2016 Jun;5:S84-S86.   PMCID: Editorial
Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes. Cancer. 2012 May;118(9):2532-40.   PMCID: PMC3235256
Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer. Journal of surgical oncology. 2012 Jul;106(1):24-30.   PMCID: PMC3370134
Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Occult Tumor Burden Predicts Disease Recurrence in Lymph Node-Negative Colorectal Cancer. Clinical Cancer Research. 2011 May;17(10):3293-303.   PMCID: PMC3096730
Myers RE, Manne SL, Wilfond B, Sifri R, Ziring B, Wolf TA, Cocroft J, Ueland A, Petrich A, Swan H, DiCarlo M, Weinberg DS. A randomized trial of genetic and environmental risk assessment (GERA) for colorectal cancer risk in primary care: Trial design and baseline findings. Contemporary clinical trials. 2011 Jan;32(1):25-31.   PMCID: PMC3006063
Manne SL, Meropol NJ, Weinberg DS, Vig H, Catts ZA, Manning C, Ross E, Shannon K, Chung DC. Facilitating Informed Decisions Regarding Microsatellite Instability Testing Among High-Risk Individuals Diagnosed With Colorectal Cancer. Journal of Clinical Oncology. 2010 Mar;28(8):1366-72.   PMCID: PMC2834496
Swoboda RK, Somasundaram R, Caputo L, Berencsi K, von Franzke P, Taylor DD, Marincola FM, Meropol NJ, Sigurdson E, Miller E, Herlyn D. Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient. International journal of cancer. 2010 Sep;127(5):1124-30.   PMCID: PMCID: PMC2897913 [Available on 2011/9/1]
Boquoi A, Chen T, Enders GH. Chemoprevention of Mouse Intestinal Tumorigenesis by the Cyclin-Dependent Kinase Inhibitor SNS-032. Cancer Prevention Research. 2009 Sep;2(9):800-6.   PMCID: PMC2819381
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Rectal Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Ray ME, Bae K, Hussain MH, Hanks GE, Shipley WU, Sandler HM. Potential Surrogate Endpoints for Prostate Cancer Survival: Analysis of a Phase III Randomized Trial. Journal of the National Cancer Institute. 2009 Feb;101(4):228-36.   PMCID: PMC2734115
Butler LM, Koh WP, Lee HP, Tseng M, Yu MC, London SJ. Prospective study of dietary patterns and persistent cough with phlegm among Chinese Singaporeans. American Journal of Respiratory and Critical Care Medicine. 2006 Feb;173(3):264-70.
Giantonio BJ, Levy DE, O'Dwyer PJ, Meropol NJ, Catalano PJ, Benson AB. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200. ANNALS OF ONCOLOGY. 2006 Sep;17(9):1399-403.
Rosen DG, Cai KQ, Luthra R, Liu JS. Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma. MODERN PATHOLOGY. 2006 Nov;19(11):1414-20.
Birbe R, Palazzo JP, Walters R, Weinberg D, Schutz S, Waldman SA. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract. Human Pathology. 2005 Feb;36(2):170-9.
Cohen SJ, Cohen RB, Meropol NJ. Targeting signal transduction pathways in colorectal cancer - More than skin deep. Journal of Clinical Oncology. 2005 Aug 10;23(23):5374-85.
Purev E, Cai DW, Miller E, Swoboda R, Klein-Szanto A, Marincola FM, Mick R, Otvos L, Wunner W, Birebent B, Somasundaram R, Wikstrand CJ, Bigner D, DeMichele A, Acs G, Berlin JA, Herlyn D. Immune responses of breast cancer patients to mutated epidermal growth factor receptor (EGF-RvIII, Delta EGF-R, and de2-7 EGF-R). Journal of Immunology. 2004 Nov 15;173(10):6472-80.
Engstrom PF, Benson A, Choti MA, Cohen AM, Doroshow JH, Fuchs C, Kiel K, Martin EW, McGinn C, Petrelli NJ, Posey JA, Skibber JM, Venook A, Yeatman TJ. NCCN Practice Guidelines for colorectal cancer. Oncology-New York. 2000 Nov;14(11A):203-12.
Tseng M, Ingram DD, Darden R, Ziegler RG, Longnecker MP. Eating frequency and risk of colorectal cancer. Nutrition and Cancer-an International Journal. 2000 Jan;36(2):170-6.
Garay CA, Engstrom PF. Chemoprevention of colorectal cancer: Dietary and pharmacologic approaches. Oncology-New York. 1999 Jan;13(1):89-97.
Geller G, Botkin JR, Green MJ, Press N, Biesecker B, Wilfond B, Grana G, Daly MB, Schneider K, Kahn MJ. Genetic testing for susceptibility to adult-onset cancer - The process and content of informed consent. JAMA-Journal of the American Medical Association. 1997 May 14;277(18):1467-74.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term colon-cancer

colon-cancer microsatellite instability carcinoma guanylyl cyclase-c expression fluorouracil micrometastases mortality identification familial adenomatous polyposis women knowledge lymph-nodes african-americans lynch-syndrome survival adjuvant chemotherapy tumors follow-up breast-cancer oxaliplatin angiogenesis marker preoperative pelvic chemoradiotherapy mice recommendations prospective randomized-trial controlled clinical-trial lung carcinomas phase-i trial total mesorectal excision IFL neoplasm recurrence reducing morbidity cells interventions egfrviii dna methylation vitamin-e mutations npm long-term survival genes disparities confidence-intervals randomized trial environmental factors food-frequency questionnaire biochemical failure metastatic colorectal cancer local excision uroguanylin coronary-heart-disease risk confers enhanced tumorigenicity receptors quantification prognosis humanized monoclonal-antibody therapy oncology group cyclic-gmp randomized-trial cytotoxic t-lymphocytes line p53 mutations guanylyl cyclase C cancer gene high-dose bevacizumab colorectal-cancer ulcerative-colitis rectal-cancer family history apoptosis-inducing ligand sphincter preservation susceptibility mutation messenger-rna diet ovarian-cancer mismatch repair plus fluorouracil Oncology factor-kappa-b systematic reviews attitudes polymorphisms discrimination human glioblastoma patient education NCCN Clinical Practice Guidelines surgery obstructive pulmonary-disease p16(ink4a) hMSH2 carcinogenesis vitamins radiation-therapy Colorectal neoplasms Decision making-Mass screening-Risk assessment-Genetic screening computer-assisted-instruction nutrition examination survey tumor-development Pathology enhanced antitumor-activity chronic bronchitis asthma-chronic obstructive pulmonary disease-diet-respiratory-signs and symptoms 1st-line treatment cell postoperative radiation-therapy homolog human tumor-antigens liver metastasis gastrointestinal malignancy lymph-node metastases nonpolyposis colorectal-cancer vaccine development therapy hMLH1 ovarian carcinoma immunohistochemistry iowa womens health meal frequency messenger-rna expression growth-factor receptor adjuvant therapy radical prostatectomy rectal polyps huntington disease tissue microarrays irinotecan recurrence randomized-trial evidence group protocol 92-02 colorectal activated protein-kinase time statistical-method androgen deprivation phenotype cytotoxic T cells colorectal carcinoma patients-antigens-tumor immunity race aid inummohistochemistry tumor-cells radiotherapy disease participation intestinal metaplasia advanced solid tumors hypermethylation colorectal liver metastases lymphocyte clone
Last updated on Friday, December 06, 2019